We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Low Price-to-Book Stocks That Are Worth Watching in February
Read MoreHide Full Article
Key Takeaways
Five low P/B stocks, IVZ, HRMY, CNXC, PAX and GPN, pass valuation screens for attractive pricing.
P/B compares market value to book value, helping flag stocks trading below intrinsic value with room to run.
The picks show solid projected 3-5 year EPS growth, supporting their value appeal.
Finding true value stocks is rarely straightforward. While tracking key financial indicators such as earnings per share and sales growth can help investors spot stocks trading below their intrinsic value, a thorough fundamental analysis using multiple metrics is essential to determine whether a stock is genuinely undervalued.
When screening for bargain stocks, investors often start with valuation measures like the price-to-earnings (P/E) and price-to-sales (P/S) ratios. However, the often-overlooked price-to-book (P/B) ratio is also a simple yet effective tool for identifying attractively priced stocks with strong growth potential.
The P/B ratio is calculated as:
P/B ratio = Market capitalization ÷ Book value of equity
The P/B ratio helps to identify low-priced stocks that have high-growth prospects. Invesco (IVZ - Free Report) , Harmony Biosciences (HRMY - Free Report) , Concentrix (CNXC - Free Report) , Patria Investments Limited (PAX - Free Report) and Global Payments (GPN - Free Report) are some such picks.
Now, let us understand the concept of book value.
What is Book Value?
There are several ways in which book value can be defined. Book value is the total value that would be left over, according to the company’s balance sheet, if it went bankrupt immediately. In other words, this is what shareholders would theoretically receive if a company liquidates all its assets after paying off all its liabilities.
It is calculated by subtracting total liabilities from the total assets of a company. In most cases, this equates to common stockholders’ equity on the balance sheet. However, depending on the company’s balance sheet, intangible assets should also be subtracted from total assets to determine book value.
Understanding P/B Ratio
By comparing the book value of equity to its market price, we get an idea of whether a company is under- or overpriced. Like P/E or P/S ratios, it is always better to compare the P/B ratio within industries.
A P/B ratio of less than one means that the stock is trading at less than its book value or the stock is undervalued and, therefore, a good buy. Conversely, a stock with a ratio greater than one can be interpreted as being overvalued or relatively expensive.
For example, a stock with a P/B ratio of 2 means that we pay $2 for every $1 of book value. Thus, the higher the P/B, the more expensive the stock.
But there is a warning. A P/B ratio of less than one can also mean that the company is earning weak or even negative returns on its assets or that the assets are overstated. In such a case, the stock should be shunned because it may be destroying shareholder value. Conversely, the stock’s price may be significantly high — thereby pushing the P/B ratio to more than one — in the likely case that it has become a takeover target, a good enough reason to own the stock.
Moreover, the P/B ratio is not without limitations. It is useful for businesses like finance, investments, insurance and banking or manufacturing companies with many liquid/tangible assets on the books. However, it can be misleading for firms with significant R&D expenditure, high debt, service companies, or those with negative earnings.
In any case, the ratio is not particularly relevant as a standalone number. One should analyze other ratios like P/E, P/S and debt to equity before arriving at a reasonable investment decision.
Screening Parameters
Price to Book (common Equity) less than X-Industry Median: A lower P/B compared with the industry average implies that there is enough room for the stock to gain.
Price to Sales less than X-Industry Median: The P/S ratio determines how much the market values every dollar of the company’s sales/revenues — a lower ratio than the industry makes the stock attractive.
Price to Earnings using F(1) estimate less than X-Industry Median: The P/E ratio (F1) values a company based on its current share price relative to its estimated earnings per share — a lower ratio than the industry is considered better.
PEG less than 1: PEG links the P/E ratio to the future growth rate of the company. The PEG ratio portrays a more complete picture than the P/E ratio. A value of less than 1 indicates that the stock is undervalued, and investors need to pay less for a stock that has bright earnings growth prospects.
Current Price greater than or equal to $5: They must all be trading at a minimum of $5 or higher.
Average 20-Day Volume greater than or equal to 100,000: A substantial trading volume ensures that the stock is easily tradable.
Zacks Rank less than or equal to #2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform irrespective of the market environment.
Value Score equal to A or B: Our research shows that stocks with a Value Score of A or B, when combined with a Zacks Rank #1 or 2, offer the best opportunities in the value investing space.
5 Low Price-to-Book Stocks
Here are five of the eight stocks that qualified the screening:
Headquartered in Atlanta, GA, Invesco Ltd. operates as an independent investment manager and offers a wide range of investment products and services.
Headquartered in Plymouth Meeting, PA, Harmony Biosciences is a pharmaceutical company making therapies for rare neurological disorders. Harmony Biosciences currently has a Zacks Rank of 1.
HRMY has a Value Score of A and a projected 3-5-year EPS growth rate of 27.11%.
Based in Newark, CA, Concentrix Corporation provides technology-enabled business services. Concentrix has a projected3-5-year EPS growth rate of 8.76%.
CNXC currently has a Zacks Rank #2 and a Value Score of A.
Based in Grand Cayman, the Cayman Islands, Patria Investments Limited is a private markets investment firm principally in Latin America. It offers asset management services to investors focusing on private equity funds, infrastructure development funds, co-investment funds, constructivist equity funds and real estate and credit funds.
Patria Investments Limited has a Zacks Rank #1 and a Value Score of A. PAX has a projected 3-5-year EPS growth rate of 15.39%.
Headquartered in Atlanta, GA, Global Payments is a leading payment technology and software company that provides payment processing technology and software solutions to merchants, financial institutions, and consumers worldwide.
GPN presently has a Zacks Rank #2 and a Value Score of A. The company has a projected 3-5-year EPS growth rate of 11.54%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
5 Low Price-to-Book Stocks That Are Worth Watching in February
Key Takeaways
Finding true value stocks is rarely straightforward. While tracking key financial indicators such as earnings per share and sales growth can help investors spot stocks trading below their intrinsic value, a thorough fundamental analysis using multiple metrics is essential to determine whether a stock is genuinely undervalued.
When screening for bargain stocks, investors often start with valuation measures like the price-to-earnings (P/E) and price-to-sales (P/S) ratios. However, the often-overlooked price-to-book (P/B) ratio is also a simple yet effective tool for identifying attractively priced stocks with strong growth potential.
The P/B ratio is calculated as:
P/B ratio = Market capitalization ÷ Book value of equity
The P/B ratio helps to identify low-priced stocks that have high-growth prospects. Invesco (IVZ - Free Report) , Harmony Biosciences (HRMY - Free Report) , Concentrix (CNXC - Free Report) , Patria Investments Limited (PAX - Free Report) and Global Payments (GPN - Free Report) are some such picks.
Now, let us understand the concept of book value.
What is Book Value?
There are several ways in which book value can be defined. Book value is the total value that would be left over, according to the company’s balance sheet, if it went bankrupt immediately. In other words, this is what shareholders would theoretically receive if a company liquidates all its assets after paying off all its liabilities.
It is calculated by subtracting total liabilities from the total assets of a company. In most cases, this equates to common stockholders’ equity on the balance sheet. However, depending on the company’s balance sheet, intangible assets should also be subtracted from total assets to determine book value.
Understanding P/B Ratio
By comparing the book value of equity to its market price, we get an idea of whether a company is under- or overpriced. Like P/E or P/S ratios, it is always better to compare the P/B ratio within industries.
A P/B ratio of less than one means that the stock is trading at less than its book value or the stock is undervalued and, therefore, a good buy. Conversely, a stock with a ratio greater than one can be interpreted as being overvalued or relatively expensive.
For example, a stock with a P/B ratio of 2 means that we pay $2 for every $1 of book value. Thus, the higher the P/B, the more expensive the stock.
But there is a warning. A P/B ratio of less than one can also mean that the company is earning weak or even negative returns on its assets or that the assets are overstated. In such a case, the stock should be shunned because it may be destroying shareholder value. Conversely, the stock’s price may be significantly high — thereby pushing the P/B ratio to more than one — in the likely case that it has become a takeover target, a good enough reason to own the stock.
Moreover, the P/B ratio is not without limitations. It is useful for businesses like finance, investments, insurance and banking or manufacturing companies with many liquid/tangible assets on the books. However, it can be misleading for firms with significant R&D expenditure, high debt, service companies, or those with negative earnings.
In any case, the ratio is not particularly relevant as a standalone number. One should analyze other ratios like P/E, P/S and debt to equity before arriving at a reasonable investment decision.
Screening Parameters
Price to Book (common Equity) less than X-Industry Median: A lower P/B compared with the industry average implies that there is enough room for the stock to gain.
Price to Sales less than X-Industry Median: The P/S ratio determines how much the market values every dollar of the company’s sales/revenues — a lower ratio than the industry makes the stock attractive.
Price to Earnings using F(1) estimate less than X-Industry Median: The P/E ratio (F1) values a company based on its current share price relative to its estimated earnings per share — a lower ratio than the industry is considered better.
PEG less than 1: PEG links the P/E ratio to the future growth rate of the company. The PEG ratio portrays a more complete picture than the P/E ratio. A value of less than 1 indicates that the stock is undervalued, and investors need to pay less for a stock that has bright earnings growth prospects.
Current Price greater than or equal to $5: They must all be trading at a minimum of $5 or higher.
Average 20-Day Volume greater than or equal to 100,000: A substantial trading volume ensures that the stock is easily tradable.
Zacks Rank less than or equal to #2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform irrespective of the market environment.
Value Score equal to A or B: Our research shows that stocks with a Value Score of A or B, when combined with a Zacks Rank #1 or 2, offer the best opportunities in the value investing space.
5 Low Price-to-Book Stocks
Here are five of the eight stocks that qualified the screening:
Headquartered in Atlanta, GA, Invesco Ltd. operates as an independent investment manager and offers a wide range of investment products and services.
IVZ has a Zacks Rank #1 and a Value Score of B. Invesco has a projected 3-5-year EPS growth rate of 20.9%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Headquartered in Plymouth Meeting, PA, Harmony Biosciences is a pharmaceutical company making therapies for rare neurological disorders. Harmony Biosciences currently has a Zacks Rank of 1.
HRMY has a Value Score of A and a projected 3-5-year EPS growth rate of 27.11%.
Based in Newark, CA, Concentrix Corporation provides technology-enabled business services. Concentrix has a projected3-5-year EPS growth rate of 8.76%.
CNXC currently has a Zacks Rank #2 and a Value Score of A.
Based in Grand Cayman, the Cayman Islands, Patria Investments Limited is a private markets investment firm principally in Latin America. It offers asset management services to investors focusing on private equity funds, infrastructure development funds, co-investment funds, constructivist equity funds and real estate and credit funds.
Patria Investments Limited has a Zacks Rank #1 and a Value Score of A. PAX has a projected 3-5-year EPS growth rate of 15.39%.
Headquartered in Atlanta, GA, Global Payments is a leading payment technology and software company that provides payment processing technology and software solutions to merchants, financial institutions, and consumers worldwide.
GPN presently has a Zacks Rank #2 and a Value Score of A. The company has a projected 3-5-year EPS growth rate of 11.54%.